State WI
Clinical Trials in Wisconsin
Recruiting clinical trials with at least one study location in Wisconsin. Data updated daily from ClinicalTrials.gov.
Top Conditions in Wisconsin
Frequently Asked Questions — Clinical Trials in Wisconsin
How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 87 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 87. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Stroke, PTSD, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Wisconsin
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05894967 N/A
Recruiting
Moderators and Mediators of Perceptual Learning
Condition
Cognitive Change
Enrollment
1,140 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT04489719 N/A
Recruiting
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Me...
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
48 pts
Location
United States
Sponsor
University of Washington
NCT07117136 N/A
Recruiting
Blinatumomab Consolidation in Real World
Condition
B-Cell Acute Lymphoblastic Leukaemia
Enrollment
200 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06210711 N/A
Recruiting
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Leve...
Condition
Traumatic Injury
Enrollment
300 pts
Location
United States
Sponsor
Baylor Research Institute
NCT06760637 Phase 3
Recruiting
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Bre...
Condition
Breast Cancer
Enrollment
1,020 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06422923 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral...
Condition
Epilepsy, Temporal Lobe
Enrollment
10 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT07343596 N/A
Recruiting
Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immun...
Condition
Oral Cavity Cancer
Enrollment
20 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05736302 N/A
Recruiting
Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Wa...
Condition
Movement Disorders
Enrollment
125 pts
Location
United States
Sponsor
University of Wisconsin, Milwa
NCT06345729 Phase 3
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants Wit...
Condition
Non-small Cell Lung Cancer
Enrollment
600 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06152627 N/A
Recruiting
Voice Therapy Per the Rehabilitation Treatment Specification System
Condition
Muscle Tension Dysphonia
Enrollment
600 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
Page 4 of 4 — 87 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology